Ben Goldacre
Judge rules pharma has ‘ethical’ transparency obligation – reaction
July 29, 2015Research and Development Ben Goldacre, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency
Both sides of a bitterly contested legal battle over a major part of the industry’s transparency drive have reacted to …
World Health Organisation calls for full trial transparency
April 14, 2015Research and Development, Sales and Marketing Ben Goldacre, EU, WHO, World Health Organisation, alltrials, clinical trials, sense about science, transparency
The World Health Organization has thrown its weight behind clinical trial transparency in a new statement on its position. WHO …
Mixed response to EMA data transparency plans
October 3, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, BMJ, Ben Goldacre, EMA, alltrials, transparency
The European Medicines Agency has passed new rules that will mandate pharma to release more of its clinical trial data …
Dr Ben Goldacre: “This is a very broken system”
October 19, 2010Medical Communications, Research and Development, Sales and Marketing Bad Science, Ben Goldacre, industry reputation, trial data
The pharma industry has its fair share of critics, but unfortunately for everybody, many are easy to dismiss – shrill, …
Researchers unearth Pfizer’s buried data
October 14, 2010Research and Development Ben Goldacre, Pfizer, publication, reboxetine, trial data
Researchers from Germany’s cost-effectiveness body IQWiG have unearthed a mountain of unpublished data from trials of Pfizer’s reboxetine that show …
